Company Overview

Update
Founded:
2002
Headquarters:
Monmouth Junction, NJ
Funding:
$5.60M
Categories:
Biotechnology

Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.

Description

Update

Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation (STM) platform to modulate signal transduction imbalances. Through research on protein networks that control biological systems, Signum is developing therapeutic agents for several skin conditions, Alzheimer's, Parkinson's, asthma and COPD. Signum’s STM technology provides many opportunities for the development of novel consumer products and pharmaceutical candidates.

Current Team (2)

Update

Funding Rounds (2) - $5.60M

Update

Offices/Locations (1)

Update
  • Office

    7 Deer Park Drive

    Suite H

    Monmouth Junction, NJ 08852

    USA